Health Winners & Losers: StemCells
Geron is up 11%.
Health stocks were dragging at the start of the week, with the Nasdaq and Amex biotechnology indices down 0.7% and 1.7%, respectively.
Among individual stocks, notable movers were:
StemCells
(STEM)
, up 29.1% at $2.26
Eurand N.V.
(EURX)
, up 14% at $10.27
Geron
(GERN) - Get Geron Corporation Report
, up 11% at $4.46
Simcere
(SCR)
, up 9.4% at $7.90
AMAG Pharmaceuticals
Scroll to Continue
TheStreet Recommends
(AMAG) - Get AMAG Pharmaceuticals, Inc. Report
, down 17.1% at $20.65
XenoPort
(XNPT)
, down 14% at $34
Life Sciences Research
(LSR)
, down 12.4% at $12.84
Pain Therapeutics
(PTIE)
, down 11.1% at $7.65
Merck
(MRK) - Get Merck & Company Inc. Report
, down 4.2% at $27.71
This article was written by a staff member of TheStreet.com.
